{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:32:44Z","timestamp":1768033964089,"version":"3.49.0"},"reference-count":22,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.5551\/jat.56945","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T22:09:12Z","timestamp":1595455752000},"page":"524-534","source":"Crossref","is-referenced-by-count":18,"title":["Correlation of the Fatty Liver Index with the Pathophysiological Abnormalities Associated with Cardiovascular Risk Markers in Japanese Men without any History of Cardiovascular Disease: Comparison with the Fibrosis-4 Score"],"prefix":"10.5551","volume":"28","author":[{"given":"Yoichi","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Shiina","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisa","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsune","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamashina","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishiro","family":"Chikamori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tomiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ratziu V, Goodman Z, Sanyal A. Current efforts and trends in the treatment of NASH. J Hepatol, 2015; 62: S65-75","DOI":"10.1016\/j.jhep.2015.02.041"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016; 64: 73-84","DOI":"10.1002\/hep.28431"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology, 1990; 11: 74-80","DOI":"10.1002\/hep.1840110114"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med, 2010; 363: 1341-1350","DOI":"10.1056\/NEJMra0912063"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Valbusa F, Agnoletti D, Scala L, Grillo C, Arduini P, Bonapace S, Calabria S, Scaturro G, Mantovani A, Zoppini G, Turcato E, Maggioni AP, Arcaro G, Targher G. Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure. Int J Cardiol, 2018; 265: 162-168","DOI":"10.1016\/j.ijcard.2018.04.129"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cicero AFG, Gitto S, Fogacci F, Rosticci M, Giovannini M, D\u2019Addato S, Andreone P, Borghi C. Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study. Eur J Intern Med, 2018; 53: 29-33","DOI":"10.1016\/j.ejim.2018.03.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pais R, Redheuil A, Cluzel P, Ratziu V, Giral P. Relationship Among Fatty Liver, Specific and Multiple-Site Atherosclerosis, and 10-Year Framingham Score. Hepatology, 2019; 69: 1453-1463","DOI":"10.1002\/hep.30223"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iwasaki Y, Tomiyama H, Shiina K, Matsumoto C, Kimura K, Fujii M, Takata Y, Yamashina A, Chikamori T. Liver stiffness and arterial stiffness\/abnormal central hemodynamics in the early stage of heart failure. Int J Cardiol Heart Vasc, 2018; 20: 32-37","DOI":"10.1016\/j.ijcha.2018.07.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, Yoshida M, Shiina K, Nagata M, Yamashina A. Continuous smoking and progression of arterial stiffening: a prospective study. J Am Coll Cardiol, 2010; 55: 1979-1987","DOI":"10.1016\/j.jacc.2009.12.042"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tomiyama H, Yamazaki M, Sagawa Y, Teraoka K, Shirota T, Miyawaki Y, Yamashina A. Synergistic effect of smoking and blood pressure on augmentation index in men, but not in women. Hypertens Res, 2009; 32: 122-126","DOI":"10.1038\/hr.2008.20"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ; Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol, 2009 Oct; 7: 1104-1112","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol, 2006; 6: 33","DOI":"10.1186\/1471-230X-6-33"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Usui Y, Tomiyama H, Hashimoto H, Takata Y, Inoue Y, Asano K, Kurohane S, Shiina K, Hirayama Y, Yamashina A. Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients. J Hypertens, 2008; 26: 117-123","DOI":"10.1097\/HJH.0b013e3282f06eb4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Olubamwo OO, Virtanen JK, Voutilainen A, Kauhanen J, Pihlajamaki J, Tuomainen TP. Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction. Eur J Gastroenterol Hepatol, 2018; 30: 1047-1054","DOI":"10.1097\/MEG.0000000000001183"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Yamashina A. Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis. Hypertension, 2017; 69: 1045-1052","DOI":"10.1161\/HYPERTENSIONAHA.117.09097"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2019; 4: 389-398","DOI":"10.1016\/S2468-1253(19)30039-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Transl Gastroenterol Hepatol, 2020; 5: 19","DOI":"10.21037\/tgh.2019.10.02"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Odaira M, Tomiyama H, Matsumoto C, Yoshida M, Shiina K, Nagata M, Yamashina A. Strength of relationships of the pulse wave velocity and central hemodynamic indices with the serum N-terminal fragment B-type natriuretic peptide levels in men: a worksite cohort study. Circ J, 2012; 76: 1928-1933","DOI":"10.1253\/circj.CJ-12-0044"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 2016; 18: 891-975","DOI":"10.1002\/ejhf.592"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L, Perseghin G. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology, 2011; 54: 145-152","DOI":"10.1002\/hep.24356"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kogler H, Schott P, Toischer K, Milting H, Van PN, Kohlhaas M, Grebe C, Kassner A, Domeier E, Teucher N, Seidler T, Kn\u00f6ll R, Maier LS, El-Banayosy A, K\u00f6rfer R, Hasenfuss G. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression. Circulation, 2006; 113: 2724-2732","DOI":"10.1161\/CIRCULATIONAHA.105.608828"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardial, 2013; 62: 485-495","DOI":"10.1016\/j.jacc.2013.04.070"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/5\/28_56945\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:58:32Z","timestamp":1619841512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/5\/28_56945\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.56945","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}